Office of Research and Sponsored Programs

The Office of Research and Sponsored Programs is dedicated to supporting and enhancing the research enterprise at the UMDNJ-SOM and UMDNJ-SOM OPTI.

• To expand the frontiers of knowledge in the basic and clinical sciences with research programs of excellence.
  
• To develop innovative research and health services programs through partnership within the university and with other health care institutions.
  
• To provide faculty with University and Funding Agencies Policies and Application Forms as well as current funding information.
  
• Ensure that all studies receive the required approvals of the IRB, IACUC, Radiation Committee, and Institutional Biosafety Committee (IBC) in addition to fulfilling all potential sponsors' requirements.
  

Carl E. Hock, Ph.D.
Associate Dean for Research
(856) 566-6066/6073
hock@umdnj.edu

Jeong-Sook H. Yoo, Ph.D.
Director
(856) 566-6066/6075
yoojh@umdnj.edu

Todd Regn, M.A.
Program Administrator
(856) 566-6066/6247
todd.regn@umdnj.edu

Sharon Owens-Davis
Administrative Analyst V
(856) 566-6066/6250
owensdsr@umdnj.edu

ORSP Location and Mailing Address:
UMDNJ-SOM
Office of Research & Sponsored Programs
University Education Center (UEC)
40 East Laurel Road, Suite1040
Stratford, NJ 08084
Phone: (856) 566-6066 (Primary contact No. for ORSP)
Fax: (856) 566-6299
Email: somorsp@umdnj.edu

Documents to be Submitted to ORSP for Grants & Contracts

• Grant/Contract Proposal/Application: Original and 3 Copies plus additional copies for the IRB, IACUC, Institutional Biosafety Committee and Radiation Safety Committee as applicable.
• Original GAFA (Transmittal and Approval Form for Grants and Contracts): Signed by the PI and PI's Chair/Director as well as Chairs/Directors of all other collaborating investigators and consultants from different departments/centers.
• Investigator Financial & Other Personal Interests Disclosure Form* (new Investigator Disclosure Form, formerly the Financial Disclosure Form, or FDF): Signed by the PI and all other key personnel as determined by the PI as well as corresponding Chairs/Directors.
  • Disclosure Form Part 1 (revised 2/22/06)
  • Discosure Form Part 2 (revised 2/22/06)

* This new two-part form replaces the Financial Disclosure Form, or FDF. If you have nothing to disclose, you only need to fill out Part 1. Please read the form instructions carefully. The policy and the form have been significantly revised. Thank you.

Link to FUNDING RESOURCES

Standing Receipt Dates for NIH Grant Applications:

New Limits on Appendix Materials for NIH Grant Applications (effective 1/3/07):

Please refer to the NIH GUIDE (11/17/06) for detailed information.

Current Rates for Grant Applications:

The following rates should be used when calculating all grant budgets:

Salaries: Current year salaries should be increased by 4% annually for subsequent grant years. The federal government will pay no portion of any salary exceeding $186,600 (effective 1/1/07; NIH GUIDE, 1/4/07)

Fringe Benefits: 35% of requested salary for all full-time employees or more than half-time employees.

Postdoctoral Fellows:

Fringe Benefits - 8% of salary plus medical insurance as follows: Postdoc only: $206/month ($2,472/yr)
Postdoc and one dependent: $472/month ($5,664/yr)
Postdoc and family (2 or more dependents): $599/month ($7,188/yr)

Current NRSA Postdoctoral Salary Rates:
(effective 10/1/05; NIH GUIDE, 1/9/06)

Graduate Students or less than half-time employees:

Fringe Benefits - 8% of salary

Note: Effective immediately, grant applications supporting graduate students should be budgeted as follows (per student): annual stipend amount, $24,000 (effective fall of 2005); the student health insurance fee, $1,917/year; and the Health Services Fee, $300/year (Total: $25,816/year).

Non-Salary Annual Increases: 5% on non-salary expenses; 5% over current rates for Research Animal Facility charges.

Indirect Costs (IC)/Facilities and Administrative (F&A) Costs:

• Federal Negotiated On-site Rate: 56.0% of modified total direct costs (MTDC) excluding equipment or patient care costs.
  (DHHS Agreement Date: 10/19/06)
  This rate (56.0%) is applicable to all on-site federally sponsored research grants, contracts, and other agreements (e.g., NIH, NSF, NASA).
• Federal Negotiated Off-site Rate: 26%
• Federal Negotiated Rate for Training Grants: 8% (e.g., HRSA)
• Industry and/or Clinical Trial Support: 25% (minimum)
  Fees and Charges Related to Industry Support: When negotiating with industry, faculty are expected to negotiate for full indirect cost recovery. 

Please check with the ORSP to ensure the above IC/F&A rates are current and for those of voluntary health organizations (e.g., ACS & AHA), foundations, and any other funding agencies.

For additional budget information, please contact the Grants and Contracts Office at 6-6100.

Institutional Review Board Fees: $1,500 for initial IRB review and additional fees for annual IRB continuation review. For current and detailed information, please contact the IRB Office at 6-2712.

Administrative Information for Grant Applications

Federal Employer ID No. (EIN or TIN)) for federal grant applications: 1221980408A5

NJ State Employer/Vendor ID No. for state grant applications: 22177530600

DUNS Number: 140757589 (NEW for SOM)

Congressional District: 01

Organizational Component Code: 05

For Use of Laboratory Animals and  IACUC Approval:

• NIH Animal Welfare Assurance Number: A3156-01
• Current AAALAC Accreditation Date: 7/11/07
• Number of copies of materials for IACUC review:
  Please contact the IACUC office at 6-6119 for detailed information.

For Use of Human Subjects and IRB Approval:

• Federal-Wide Assurance (FWA) Number: FWA00004917
  Please note that this replaces the old Human Assurance No: M-1464
• Number of copies of material for IRB review:
  Please contact the IRB office at 6-2712 for detailed information.

PLEASE NOTE that all key personnel involved in the design or conduct of
a study involving human subjects MUST complete the Research Protection
for Human Subjects review and examination. Copies of the Completion
Certificate(s) MUST be provided to the IRB Office. NO IRB Approval
letters will be issued without submission of the required Certificate(s).

To request registration for this course, please fill out the form
located at: http://www.umdnj.edu/hsweb/education_training/index.htm

Authorized Official Signing for UMDNJ-SOM:

Carl E. Hock, Ph.D.
Associate Dean for Research
Office of Research and Sponsored Program
40 East Laurel Road, Suite 1040
UMDNJ-School of Osteopathic Medicine
Stratford, NJ 08084
Phone: (856) 566-6066
Fax: (856) 566-6299
hock@umdnj.edu

Administrative Office to be Notified if Award is Made and to Whom Checks Should be Sent:

Gerald W. Sabawa, Manager
Grants and Contracts
40 East Laurel Road, Suite 1052
UMDNJ-School of Osteopathic Medicine
Stratford, NJ 08084
Phone: (856) 566-6102
Fax: (856) 566-6107
sabawagw@umdnj.edu

NIH Information:

• NIH Grants Policy and Guidance (12/1/03 Version)
• PHS 398 Forms and Instructions (Revised 4/06):             
  For new/competing renewal applications.
  Please read the NIH Guide Notice (4/7/06) for important changes to this version before preparing the application.

• PHS 2590 Forms and Instructions (Revised 4/06):           
  For noncompeting applications (progress reports).
  Please read the NIH Guide Notice (4/7/06) for important changes to this version before preparing the application.

SOM's Customized NIH Forms (NIH 4/06 Rev. Forms):

Please note that the Forms have been updated using the new NIH Forms (4/06 Rev.).

• PHS 398 Face Page (Microsoft Word)
• PHS 398 Face Page (Acrobat File)
• PHS 398 Checklist (Microsoft Word)
• PHS 398 Checklist (Acrobat File)
  The PHS 398 Form (with the Instructions and Guide Notice (linked above) must be used effective 5/10/06; otherwise, the application will be returned to the applicant wiithout review.

• PHS 2590 Face Page (Microsoft Word)
• PHS 2590 Face Page (Acrobat File)
  The PHS 2590 Form (with the Instructions and Guide Notice linked above) must be used effective 6/1/06 (Application Receipt Date).

Change in Business Process: Replacing PI Signature on the Application with an Institutional Compliance Requirement

Effective with PHS398 applications prepared for submission/receipt dates on/after May 10, 2006, the signature of the Principal Investigator is no longer required as a part of a submitted application. Instead, a new compliance requirement is now implemented whereby the applicant organization agrees to secure and retain at the organization a written assurance from the Principal Investigator (PI) prior to submitting an application to the PHS.  While this assurance is no longer required as part of the submitted application, it remains a compliance requirement.  Therefore, organizations must retain a unique signature and date for each submitted application.   This assurance must be available to the sponsoring agency or other authorized HHS or Federal officials upon request. 

Such an assurance must include at least the following certifications:  (1) that the information submitted within the application is true, complete and accurate to the best of the PI's knowledge; (2) that any false, fictitious, or fraudulent statements or claims may subject the PI to criminal, civil, or administrative penalties; and (3) that the PI agrees to accept responsibility for the scientific conduct of the project and to provide the required progress reports if a grant is awarded as a result of the application.  When multiple PIs are proposed in an application, this assurance must be retained for all named PIs.

Please use the following form for the new compliance requirement:

PI Assurance Form (PIAF) (Word File)
PI Assurance Form (PIAF) (Acrobat File)

Intramural Research Programs:

• Foundation of UMDNJ Annual Faculty Research Grants Program - Customized Instructions and Fillable Forms for SOM facuty (2007-08).

• Medical Student Summer Research Program 

Materials Transfer Agreements (MTAs) and Other Research Related Contracts/Agreements:

Forward to the ORSP (attn.: Carl E. Hock, Ph.D.) all documents and the contact information.  Electronic documents are always preferred for initial processing for review.

Note: Two originals signed by principal investigators are required for processing.